Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection, page-229

This has already happened to MSB with the Nasdaq listing.
It happened at a difficult time to raise capital.
However despite all the efforts of the shorters assisted by very vocal commentators in the financial media, the listing was successful.
Others failed at that time.

The situation with MSB is vastly different now because of the progress with the FDA. Once the first approval is in, several things follow
- partnerships agreements
- more efficiency and confidence from the FDA in MSB's cells.
- then faster approvals
- as approvals get closer, more partnerships line up.

This is just the synergistic nature of things. SI and his team are strategists who do not bend under pressure.
They have and remain, fixed on the end goals.
I don't know about the calibre of Weebit nano's Board and Executive staff but I'd bet it's not the same league as MSB's.